Advertisement
Original article| Volume 80, ISSUE 1, P56-63, July 2022

Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy

  • Hiroki Usuku
    Affiliations
    Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan

    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Seiji Takashio
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Eiichiro Yamamoto
    Correspondence
    Corresponding author at: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Toshihiro Yamada
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Koichi Egashira
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Mami Morioka
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Masato Nishi
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Takashi Komorita
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Fumi Oike
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Noriaki Tabata
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Masanobu Ishii
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Kenshi Yamanaga
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Koichiro Fujisue
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Daisuke Sueta
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Yuichiro Arima
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Satoshi Araki
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Seitaro Oda
    Affiliations
    Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Yohei Misumi
    Affiliations
    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

    Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Hiroaki Kawano
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Kenichi Matsushita
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

    Division of Advanced Cardiovascular Therapeutics, Kumamoto University Hospital, Kumamoto, Japan
    Search for articles by this author
  • Mitsuharu Ueda
    Affiliations
    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

    Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Hirotaka Matsui
    Affiliations
    Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan

    Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
  • Kenichi Tsujita
    Affiliations
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

    Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
    Search for articles by this author
Published:March 10, 2022DOI:https://doi.org/10.1016/j.jjcc.2022.02.010

      Highlights

      • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is becoming increasingly recognized.
      • Echocardiographic prognostic marker of ATTRwt-CM was not fully clarified.
      • Our study showed that RV-GLS was significant prognostic marker for ATTRwt-CM.
      • RV function is important for the prognosis in patients with ATTRwt-CM.

      Abstract

      Background

      This study was performed to investigate whether right ventricular global longitudinal strain (RV-GLS) provides prognostic information in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM).

      Methods and results

      Among 129 patients who were diagnosed with ATTRwt-CM at Kumamoto University Hospital from December 2002 to December 2019, 111 patients who had enough information for two-dimensional speckle tracking imaging were retrospectively analyzed. During a median follow-up of 615 days, 26 cardiovascular deaths occurred. Compared with patients in the non-event group, those in the cardiovascular death group were significantly older (81.1 ± 7.4 years vs. 78.2 ± 6.2 years, p = 0.009) and had significantly higher interventricular septal thickness in diastole (16.6 ± 3.1 mm vs. 15.3 ± 2.4 mm, p = 0.048), lower RV-GLS (10.9 ± 2.7% vs. 12.8 ± 3.5%, p = 0.010), and lower right ventricular free wall longitudinal strain (RVFWLS) (13.1 ± 3.3% vs. 15.5 ± 3.8%, p = 0.004). In the univariate Cox proportional hazard analysis, age, left atrial volume index (LAVI), RV-GLS, and RVFWLS were significantly associated with cardiovascular death [age, hazard ratio (HR), 1.10; 95% confidence interval (CI), 1.02–1.19, p = 0.010; LAVI, HR, 1.02; 95% CI, 1.00–1.03, p = 0.009; RV-GLS, HR, 0.86; 95% CI, 0.75–0.97, p = 0.017; RVFWLS, HR 0.89; 95% CI, 0.79–1.00; p = 0.041]. Multivariable Cox proportional hazard analysis showed RV-GLS was significantly and independently associated with cardiovascular death in patients with ATTRwt-CM (HR, 0.86; 95% CI, 0.74–0.99; p = 0.038). Receiver operating characteristic analysis showed that the area under the curve of RV-GLS for cardiovascular death was 0.668 and that the best cut-off value of RV-GLS was 11.59% (sensitivity, 69.2%; specificity, 63.5%). In the Kaplan–Meier analysis, patients with ATTRwt-CM who had low RV-GLS (<11.59%) had a significantly higher probability of total cardiovascular death (p = 0.004) and heart failure-related hospitalization (p = 0.013).

      Conclusion

      RV-GLS has significant prognostic value in patients with ATTRwt-CM and provides greater prognostic power than conventional echocardiographic findings.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Izumiya Y.
        • Takashio S.
        • Oda S.
        • Yamashita Y.
        • Tsujita K.
        Recent advances in diagnosis and treatment of cardiac amyloidosis.
        J Cardiol. 2018; 71: 135-143
        • Falk R.H.
        • Dubrey S.W.
        Amyloid heart disease.
        Prog Cardiovasc Dis. 2010; 52: 347-361
        • Castano A.
        • Drachman B.M.
        • Judge D.
        • Maurer M.S.
        Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.
        Heart Fail Rev. 2015; 20: 163-178
        • Grogan M.
        • Scott C.G.
        • Kyle R.A.
        • Zeldenrust S.R.
        • Gertz M.A.
        • Lin G.
        • et al.
        Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system.
        J Am Coll Cardiol. 2016; 68: 1014-1020
        • Gillmore J.D.
        • Damy T.
        • Fontana M.
        • Hutchinson M.
        • Lachmann H.J.
        • Martinez-Naharro A.
        • et al.
        A new staging system for cardiac transthyretin amyloidosis.
        Eur Heart J. 2018; 39: 2799-2806
        • Amundsen B.H.
        • Helle-Valle T.
        • Edvardsen T.
        • Torp H.
        • Crosby J.
        • Lyseggen E.
        • et al.
        Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging.
        J Am Coll Cardiol. 2006; 47: 789-793
        • Buss S.J.
        • Emami M.
        • Mereles D.
        • Korosoglou G.
        • Kristen A.V.
        • Voss A.
        • et al.
        Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
        J Am Coll Cardiol. 2012; 60: 1067-1076
        • Iacoviello M.
        • Citarelli G.
        • Antoncecchi V.
        • Romito R.
        • Monitillo F.
        • Leone M.
        • et al.
        Right ventricular longitudinal strain measures independently predict chronic heart failure mortality.
        Echocardiography. 2016; 33: 992-1000
        • Falk R.H.
        Diagnosis and management of the cardiac amyloidoses.
        Circulation. 2005; 112: 2047-2060
        • Lang R.M.
        • Badano L.P.
        • Mor-Avi V.
        • Afilalo J.
        • Armstrong A.
        • Ernande L.
        • et al.
        Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        J Am Soc Echocardiogr. 2015; 28: 1-39.e14
        • Nagueh S.F.
        • Smiseth O.A.
        • Appleton C.P.
        • Byrd 3rd, B.F.
        • Dokainish H.
        • Edvardsen T.
        • et al.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        J Am Soc Echocardiogr. 2016; 29: 277-314
        • Zoghbi W.A.
        • Adams D.
        • Bonow R.O.
        • Enriquez-Sarano M.
        • Foster E.
        • Grayburn P.A.
        • et al.
        Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Maurer M.S.
        • Schwartz J.H.
        • Gundapaneni B.
        • Elliott P.M.
        • Merlini G.
        • Waddington-Cruz M.
        • et al.
        Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.
        N Engl J Med. 2018; 379: 1007-1016
        • Konstam M.A.
        • Kiernan M.S.
        • Bernstein D.
        • Bozkurt B.
        • Jacob M.
        • Kapur N.K.
        • et al.
        Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association.
        Circulation. 2018; 137: e578-e622
        • Haddad F.
        • Doyle R.
        • Murphy D.J.
        • Hunt S.A.
        Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.
        Circulation. 2008; 117: 1717-1731
      1. Moñivas Palomero V, Durante-Lopez A, Sanabria MT, Cubero JS, González-Mirelis J, Lopez-Ibor JV, et al. Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis. J Am Soc Echocardiogr 2019;32:845–53.e1.

        • Bodez D.
        • Ternacle J.
        • Guellich A.
        • Galat A.
        • Lim P.
        • Radu C.
        • et al.
        Prognostic value of right ventricular systolic function in cardiac amyloidosis.
        Amyloid. 2016; 23: 158-167
        • Ng B.
        • Connors L.H.
        • Davidoff R.
        • Skinner M.
        • Falk R.H.
        Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.
        Arch Intern Med. 2005; 165: 1425-1429
        • Giusca S.
        • Dambrauskaite V.
        • Scheurwegs C.
        • D’Hooge J.
        • Claus P.
        • Herbots L.
        • et al.
        Deformation imaging describes right ventricular function better than longitudinal displacement of the tricuspid ring.
        Heart. 2010; 96: 281-288
        • Melenovsky V.
        • Hwang S.J.
        • Lin G.
        • Redfield M.M.
        • Borlaug B.A.
        Right heart dysfunction in heart failure with preserved ejection fraction.
        Eur Heart J. 2014; 35: 3452-3462
        • Maffessanti F.
        • Gripari P.
        • Tamborini G.
        • Muratori M.
        • Fusini L.
        • Alamanni F.
        • et al.
        Evaluation of right ventricular systolic function after mitral valve repair: a two-dimensional Doppler, speckle-tracking, and three-dimensional echocardiographic study.
        J Am Soc Echocardiogr. 2012; 25: 701-708
        • Castano A.
        • Haq M.
        • Narotsky D.L.
        • Goldsmith J.
        • Weinberg R.L.
        • Morgenstern R.
        • et al.
        Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis.
        JAMA Cardiol. 2016; 1: 880-889
        • Leather H.A.
        • Ama R.
        • Missant C.
        • Rex S.
        • Rademakers F.E.
        • Wouters P.F.
        Longitudinal but not circumferential deformation reflects global contractile function in the right ventricle with open pericardium.
        Am J Physiol Heart Circ Physiol. 2006; 290: H2369-H2375
        • Hamada-Harimura Y.
        • Seo Y.
        • Ishizu T.
        • Nishi I.
        • Machino-Ohtsuka T.
        • Yamamoto M.
        • et al.
        Incremental prognostic value of right ventricular strain in patients with acute decompensated heart failure.
        Circ Cardiovasc Imaging. 2018; 11e007249
        • Chacko L.
        • Martone R.
        • Bandera F.
        • Lane T.
        • Martinez-Naharro A.
        • Boldrini M.
        • et al.
        Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
        Eur Heart J. 2020; 41: 1439-1447
        • Nagata Y.
        • Takeuchi M.
        • Mizukoshi K.
        • Wu V.C.
        • Lin F.C.
        • Negishi K.
        • et al.
        Intervendor variability of two-dimensional strain using vendor-specific and vendor-independent software.
        J Am Soc Echocardiogr. 2015; 28: 630-641